Biontech Se Sponsored Adr (BNTX), Genmab (Otc) (GMAB) announced an update on their ongoing clinical study.

BioNTech SE will announce its financial results for the first quarter of 2025 on May 5, 2025, and will hold a conference call and webcast at 8:00 a.m. EDT (2:00 p.m. CEST) to discuss these results and ...

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...

BioNTech SE will release its financial results for the second quarter of 2025 on August 4, 2025, and will hold a conference call and webcast that day at 8:00 a.m. EDT to discuss these results and ...

On Wednesday, BioNTech SE (NASDAQ:BNTX) agreed to acquire Biotheus, a clinical-stage biotechnology company focused on discovering and developing antibodies for oncological or inflammatory diseases.

ClearBridge Investments, an investment management company, released its “ClearBridge Value Equity Strategy” first quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

BioNTech's guidance points to a big drop in revenue this year. The company is using its cash reserves to fund 24 clinical trials. Its shares are down more than 16% so far this year. The company ...

Last week, Moderna and BioNTech partner Pfizer said their new COVID vaccines work against the current dominant strain of omicron growing across the U.S. Today, the Biden administration announced a ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, its ...

The US agreed to pay vaccine partners Pfizer Inc. and BioNTech SE $3.2 billion in a deal for 105 million of their messenger RNA shots against Covid-19. The deal is for doses for adults, children and ...